US Patent Issued to D4 Labs on March 31 for "Adjuvanted protein vaccines comprising modified full-length spike protein of SARS-CoV-2 composition and methods of use" (California, Maryland Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,146, issued on March 31, was assigned to D4 Labs LLC (Pacific Grove, Calif.).

"Adjuvanted protein vaccines comprising modified full-length spike protein of SARS-CoV-2 composition and methods of use" was invented by David Craig Wright (Pacific Grove, Calif.), Michael Bowe (Marina, Calif.), Emily Wright (Covina, Calif.) and Peter Pushko (Frederick, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are adjuvanted protein vaccines comprising: a non-phospholipid liposome and one or more proteins, wherein the protein is encapsulated within the non-phospholipid liposome, and wherein the protein is selected from: (i) a modified full-lengt...